dauricine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Liu, J; Ma, S; Shi, S; Wang, Y; Wu, X; Xie, L; Xu, B; Ye, S | 1 |
1 other study(ies) available for dauricine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Dauricine interferes with SARS-CoV-2 variants infection by blocking the interface between RBD and ACE2.
Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; COVID-19; Humans; Protein Binding; SARS-CoV-2 | 2023 |